Literature DB >> 34027906

Coronavirus disease 2019 and kidney injury.

Shweta Punj1, Eudora Eng, Aneesha A Shetty.   

Abstract

PURPOSE OF REVIEW: In this paper, we seek to review coronavirus disease 2019 (COVID-19) associated kidney injury with a focus on what is known about pathophysiology. RECENT
FINDINGS: Kidney injury is a common complication of SARS-CoV-2 infection and is associated with increased morbidity and mortality. Acute tubular necrosis and glomerular injury are two common findings. Direct viral effect, endothelial dysfunction, and podocyte and tubular epithelial injury have been described. COVID-19-related glomerular injury may also be associated with high-risk APOL1 genotype.
SUMMARY: Data on COVID-19 renal involvement have suggested novel mechanisms of kidney injury that need to be further elucidated. More data are needed on renal involvement in milder disease, renal-specific therapeutic interventions, and long-term sequelae.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 34027906     DOI: 10.1097/MNH.0000000000000718

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  7 in total

1.  Kidney involvement and histological findings in two pediatric COVID-19 patients.

Authors:  Jessica Serafinelli; Antonio Mastrangelo; William Morello; Valeria Fanny Cerioni; Adib Salim; Manuela Nebuloni; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2021-08-18       Impact factor: 3.714

2.  Spectrum of Kidney Injury Following COVID-19 Disease: Renal Biopsy Findings in a Single Italian Pathology Service.

Authors:  Alessandro Gambella; Antonella Barreca; Luigi Biancone; Dario Roccatello; Licia Peruzzi; Luca Besso; Carolina Licata; Angelo Attanasio; Mauro Papotti; Paola Cassoni
Journal:  Biomolecules       Date:  2022-02-12

3.  Clinical characteristics of COVID-19 patients with complications: implications for management.

Authors:  Fen Lan; Chen Zhu; Rui Jin; Lingxiao Zhou; Yue Hu; Jianping Zhao; Shuyun Xu; Yang Xia; Wen Li
Journal:  Ther Adv Chronic Dis       Date:  2021-09-11       Impact factor: 5.091

Review 4.  Serum hydroxybutyrate dehydrogenase and COVID-19 severity and mortality: a systematic review and meta-analysis with meta-regression.

Authors:  Angelo Zinellu; Panagiotis Paliogiannis; Ciriaco Carru; Arduino A Mangoni
Journal:  Clin Exp Med       Date:  2021-11-19       Impact factor: 5.057

5.  Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers.

Authors:  Mahavir Singh; Sathnur Pushpakumar; Nia Bard; Yuting Zheng; Rubens P Homme; Sri Prakash L Mokshagundam; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2022-06-22       Impact factor: 3.842

6.  Suppressed renoprotective purines in COVID-19 patients with acute kidney injury.

Authors:  Edwin K Jackson; Georgios D Kitsios; Michael Y Lu; Caitlin M Schaefer; Cathy J Kessinger; Bryan J McVerry; Alison Morris; Bernard J C Macatangay
Journal:  Sci Rep       Date:  2022-10-17       Impact factor: 4.996

7.  Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.

Authors:  Abdisa Tufa; Tewodros Haile Gebremariam; Tsegahun Manyazewal; Yidnekachew Asrat; Tewodros Getinet; Tsegaye Gebreyes Hundie; Dominic-Luc Webb; Per M Hellström; Solomon Genet
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.